Current Science

Open Access Open Access  Restricted Access Subscription Access

Association between Serum Tumour Necrosis Factor-α Concentrations and Chronic Obstructive Pulmonary Disease


Affiliations
1 Department of Respiratory Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan, China
2 Department of Respiratory Medicine, the First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
 

Tumour necrosis factor-α (TNF-α) is an important pro-inflammatory cytokine and has been implicated to play a role in the systemic inflammation of patients with chronic obstructive pulmonary disease (COPD). We conducted a meta-analysis to assess the association between serum TNF-α concentration and COPD. PubMed and Embase were searched for eligible studies. Data were extracted and standard mean differences (SMDs) and 95% confidence intervals (CI) were calculated. Thirty-three studies were included in the meta-analysis. The serum TNF-α concentrations were higher in patients with stable COPD than healthy controls (SMD = 0.64 pg/ml, 95%CI 0.43, 0.86). COPD patients with normal to high body mass index (BMI) and low BMI had increased TNF-α concentration compared with healthy controls (SMD = 1.14 pg/ml, 95%CI 0.36, 1.92; SMD = 1.62 pg/ml, 95%CI 0.89, 2.35 respectively). There was notable significance in serum TNF-α level between underweight and normal weight COPD patients (SMD = 0.68, 95%CI 0.43, 0.92). The meta-analysis indicates that patients with stable COPD have higher serum TNF-α concentration than healthy controls, and the higher circulating TNF-α levels in COPD patients with weight loss may suggest its valuable role in the evaluation of systemic inflammatory responses in stable COPD patients.

Keywords

Chronic Obstructive Pulmonary Disease, Meta-Analysis, Tumour Necrosis Factor-α Systemic Inflammation.
User
Notifications
Font Size

  • Global initiative for chronic obstructive lung disease. Gold workshop report: Global strategy for diagnosis, management and prevention of COPD (updated 2015); http://www.Goldcopd.Org/guidelines/guidelines-global-strategy-for-diagnosis-management

  • Davidson, W. J., Verity, W. S., Traves, S. L., Leigh, R., Ford, G. T. and Eves, N. D., Effect of incremental exercise on airway and systemic inflammation in patients with COPD. J. Appl. Physiol., 2012, 112, 2049-2056.

  • Matera, M. G., Martuscelli, E. and Cazzola, M., Pharmacological modulation of beta-adrenoceptor function in patients with coexisting chronic obstructive pulmonary disease and chronic heart failure. Pulm. Pharmacol. Therap., 2010, 23, 1-8.

  • Bhatnagar, S., Panguluri, S. K., Gupta, S. K., Dahiya, S., Lundy, R. F. and Kumar, A., Tumour necrosis factor-alpha regulates distinct molecular pathways and gene networks in cultured skeletal muscle cells. PLoS ONE, 2010, 5, e13262.

  • de Godoy, I., Donahoe, M., Calhoun, W. J., Mancino, J. and Rogers, R. M., Elevated TNF-alpha production by peripheral blood monocytes of weight-losing COPD patients. Am. J. Resp. Crit.Care Med., 1996, 153, 633-637.

  • Uzum, A. K., Aydin, M. M., Tutuncu, Y., Omer, B., Kiyan, E. and Alagol, F., Serum ghrelin and adiponectin levels are increased but serum leptin level is unchanged in low weight chronic obstructive pulmonary disease patients. Eur. J. Intern. Med., 2014, 25, 364-369.

  • Eker, S., Ayaz, L., Tamer, L. and Ulubas, B., Leptin, visfatin, insulin resistance, and body composition change in chronic obstructive pulmonary disease. Scand. J. Clin. Lab. Invest., 2010, 70, 40-44.

  • Oncel, C., Baser, S., Cam, M., Akdag, B., Taspinar, B. and Evyapan, F., Peripheral neuropathy in chronic obstructive pulmonary disease. COPD, 2010, 7, 11-16.

  • Huertas, A. et al., Bone marrow-derived progenitors are greatly reduced in patients with severe COPD and low-bmi. Respir. Physiol. Neurobiol., 2010, 170, 23-31.

  • Karadag, F., Karul, A. B., Cildag, O., Altun, C. and Gurgey, O., Determinants of BMI in patients with COPD. Respirology, 2004, 9, 70-75.

  • Liu, S. F., Chin, C. H., Wang, C. C. and Lin, M. C., Correlation between serum biomarkers and BODE index in patients with stable COPD. Respirology, 2009, 14, 999-1004.

  • Koechlin, C., Couillard, A., Cristol, J. P., Chanez, P., Hayot, M., Le Gallais, D. and Prefaut, C., Does systemic inflammation trigger local exercise-induced oxidative stress in COPD? Eur. Respir. J., 2004, 23, 538-544.

  • Rabinovich, R. A. et al., Increased tumour necrosis factor - plasma levels during moderate-intensity exercise in COPD patients. Eur. Respir. J., 2003, 21, 789-794.

  • Higgins, J. P. and Thompson, S. G., Quantifying heterogeneity in a meta-analysis. Stat. Med., 2002, 21, 1539-1558.

  • DerSimonian, R. and Laird, N., Meta-analysis in clinical trials. Control Clin. Trials, 1986, 7, 177-188.

  • Egger, M., Davey Smith, G., Schneider, M. and Minder, C., Bias in meta-analysis detected by a simple graphical test. BMJ, 1997, 315, 629-634.

  • Gagnon, P. et al., Preserved function and reduced angiogenesis potential of the quadriceps in patients with mild COPD. Respiratory Res., 2014, 15, 4.

  • Wang, X. R. et al., Increased serum levels of lipocalin-1 and -2 in patients with stable chronic obstructive pulmonary disease. Int. J. Chronic Obstr. Pulm. Dis., 2014, 9, 543-549.

  • Ju, C. R. and Chen, R. C., Serum myostatin levels and skeletal muscle wasting in chronic obstructive pulmonary disease. Respir. Med., 2012, 106, 102-108.

  • Bai, P., Sun, Y., Jin, J., Hou, J., Li, R., Zhang, Q. and Wang, Y., Disturbance of the opg/rank/rankl pathway and systemic inflammation in COPD patients with emphysema and osteoporosis. Respir. Res., 2011, 12, 157.

  • von Haehling, S., Hopkinson, N. S., Polkey, M. I., Niethammer, M., Anker, S. D. and Genth-Zotz, S., Elevated TNF-α production in whole blood in patients with severe COPD: the potential link to disease severity. Wien. Klin. Wochenschr., 2009, 121, 303-308.

  • Ying, B. W. et al., Plasma ghrelin levels and weight loss in chinese uygur patients with chronic obstructive pulmonary disease. J. Int. Med. Res., 2008, 36, 1371-1377.

  • Shaker, S. B. et al., Identification of patients with chronic obstructive pulmonary disease (COPD) by measurement of plasma biomarkers. Clin. Respir. J., 2008, 2, 17-25.

  • Karadag, F., Kirdar, S., Karul, A. B. and Ceylan, E., The value of c-reactive protein as a marker of systemic inflammation in stable chronic obstructive pulmonary disease. Eur. J. Int. Med., 2008, 19, 104-108.

  • Karadag, F., Karul, A. B., Cildag, O., Yilmaz, M. and Ozcan, H., Biomarkers of systemic inflammation in stable and exacerbation phases of COPD. Lung, 2008, 186, 403-409.

  • Jammes, Y., Steinberg, J. G., Ba, A., Delliaux, S. and Bregeon, F., Enhanced exercise-induced plasma cytokine response and oxidative stress in COPD patients depend on blood oxygenation. Clin.Physiol. Funct. Imaging, 2008, 28, 182-188.

  • Higashimoto, Y. et al., Systemic inflammation in chronic obstructive pulmonary disease and asthma: similarities and differences. Respirology, 2008, 13, 128-133.

  • Vogiatzis, I., Stratakos, G., Simoes, D. C., Terzis, G., Georgiadou, O., Roussos, C. and Zakynthinos, S., Effects of rehabilitative exercise on peripheral muscle TNF-α, IL-6, IGF-I and MyaD expression in patients with COPD. Thorax, 2007, 62, 950-956.

  • Tomoda, K., Yoshikawa, M., Itoh, T., Tamaki, S., Fukuoka, A., Komeda, K. and Kimura, H., Elevated circulating plasma adiponectin in underweight patients with COPD. Chest, 2007, 132, 135-140.

  • Shin, K. C., Chung, J. H. and Lee, K. H., Effects of TNF-alpha and leptinon weight loss in patients with stable chronic obstructive pulmonary disease. Kor. J. Intern. Med., 2007, 22, 249-255.

  • Karadag, F., Ozcan, H., Karul, A. B., Ceylan, E. and Cildag, O., Correlates of erectile dysfunction in moderate-to-severe chronic obstructive pulmonary disease patients. Respirology, 2007, 12, 248-253.

  • Foschino Barbaro, M. P., Carpagnano, G. E., Spanevello, A., Cagnazzo, M. G. and Barnes, P. J., Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease.Int. J. Immunopathol. Pharmacol., 2007, 20, 753-763.

  • Yende, S. et al., Inflammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects. Thorax, 2006, 61, 10-16.

  • Yang, Y. M., Sun, T. Y. and Liu, X. M., The role of serum leptin and tumour necrosis factor-alpha in malnutrition of male chronic obstructive pulmonary disease patients. Chin. Med. J., 2006, 119, 628-633.

  • Van Helvoort, H. A., Heijdra, Y. F., Thijs, H. M., Vina, J., Wanten, G. J. and Dekhuijzen, P. N., Exercise-induced systemic effects in muscle-wasted patients with COPD. Med. Sci. Sports Exercise, 2006, 38, 1543-1552.

  • Palange, P. et al., Circulating haemopoietic and endothelial progenitor cells are decreased in COPD. Eur. Respir. J., 2006, 27, 529-541.

  • Luo, F. M., Liu, X. J., Li, S. Q., Wang, Z. L., Liu, C. T. and Yuan, Y. M., Circulating ghrelin in patients with chronic obstructive pulmonary disease. Nutrition, 2005, 21, 793-798.

  • Itoh, T. et al., Elevated plasma ghrelin level in underweight patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med., 2004, 170, 879-882.

  • Calikoglu, M. et al., Leptin and TNF-alpha levels in patients with chronic obstructive pulmonary disease and their relationship to nutritional parameters. Respir. Int. Rev. Thorac. Dis., 2004, 71, 45-50.

  • Debigare, R., Marquis, K., Cote, C. H., Tremblay, R. R., Michaud, A., LeBlanc, P. and Maltais, F., Catabolic/anabolic balance and muscle wasting in patients with COPD. Chest, 2003, 124, 83-89.

  • Yuan, Y., Wang, Z. and Liu, C., [Preliminary investigation of effect of serum leptin on nutritional state of copd patients]. Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chin.J. Tuberculosis Respir. Dis., 2000, 23, 292-295.

  • Takabatake, N. et al., Circulating levels of soluble FAS ligand and soluble FAS in patients with chronic obstructive pulmonary disease. Respir. Med., 2000, 94, 1215-1220.

  • Takabatake, N. et al., Circulating leptin in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med., 1999, 159, 1215-1219.

  • Yasuda, N. et al., An increase of soluble FAS, an inhibitor of apoptosis, associated with progression of COPD. Resp. Med., 1998, 92, 993-999.

  • Agusti, A. G., Noguera, A., Sauleda, J., Sala, E., Pons, J. and Busquets, X., Systemic effects of chronic obstructive pulmonary disease. Eur. Res. J., 2003, 21, 347-360.

  • Wouters, E. F., Chronic obstructive pulmonary disease. 5: systemic effects of COPD. Thorax, 2002, 57, 1067-1070.

  • Dickens, J. A., Miller, B. E., Edwards, L. D., Silverman, E. K., Lomas, D. A. and Tal-Singer, R., COPD association and repeatability of blood biomarkers in the eclipse cohort. Respir. Res., 2011, 12, 146.

  • Di Francia, M., Barbier, D., Mege, J. L. and Orehek, J., Tumour necrosis factor-alpha levels and weight loss in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med., 1994, 150, 1453-1455.

  • Landbo, C., Prescott, E., Lange, P., Vestbo, J. and Almdal, T. P., Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med., 1999, 160, 1856-1861.

  • Schols, A. M. W. J., Slangen, J., Volovics, L. and Wouters, E. F. M., Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med., 1998, 157, 1791-1797.

  • Agusti, A. G. et al., Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med., 2002, 166, 485-489.


Abstract Views: 290

PDF Views: 94




  • Association between Serum Tumour Necrosis Factor-α Concentrations and Chronic Obstructive Pulmonary Disease

Abstract Views: 290  |  PDF Views: 94

Authors

Xiao-Feng Xiong
Department of Respiratory Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan, China
Jia Wei
Department of Respiratory Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan, China
Yi-Hua Lin
Department of Respiratory Medicine, the First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
De-Yun Cheng
Department of Respiratory Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan, China

Abstract


Tumour necrosis factor-α (TNF-α) is an important pro-inflammatory cytokine and has been implicated to play a role in the systemic inflammation of patients with chronic obstructive pulmonary disease (COPD). We conducted a meta-analysis to assess the association between serum TNF-α concentration and COPD. PubMed and Embase were searched for eligible studies. Data were extracted and standard mean differences (SMDs) and 95% confidence intervals (CI) were calculated. Thirty-three studies were included in the meta-analysis. The serum TNF-α concentrations were higher in patients with stable COPD than healthy controls (SMD = 0.64 pg/ml, 95%CI 0.43, 0.86). COPD patients with normal to high body mass index (BMI) and low BMI had increased TNF-α concentration compared with healthy controls (SMD = 1.14 pg/ml, 95%CI 0.36, 1.92; SMD = 1.62 pg/ml, 95%CI 0.89, 2.35 respectively). There was notable significance in serum TNF-α level between underweight and normal weight COPD patients (SMD = 0.68, 95%CI 0.43, 0.92). The meta-analysis indicates that patients with stable COPD have higher serum TNF-α concentration than healthy controls, and the higher circulating TNF-α levels in COPD patients with weight loss may suggest its valuable role in the evaluation of systemic inflammatory responses in stable COPD patients.

Keywords


Chronic Obstructive Pulmonary Disease, Meta-Analysis, Tumour Necrosis Factor-α Systemic Inflammation.

References





DOI: https://doi.org/10.18520/cs%2Fv110%2Fi2%2F172-179